One kind of stem cell, those referred to as ‘facultative’, form part—together with other cells—of tissues and organs. There is apparently nothing that differentiates these cells from the others.
News & Media mentions
Scientia Crastina is a platform aimed at early career scientists for the
discussion of academic communication and the dissemination of science.
Diario Médico reports on a study by Ernest Giralt’s lab (two pages) published in the Journal of Controlled Release on the design of a peptide capable of eliminating tumour cells.
The magazine Quo has published an article by Cristina Sáez on the breakthroughs and future treatments for cancer.
What they say about us
Joan J. Guinovart
«We are at an unprecedented position in history to bring about change in the way we deal with human health and disease.»
«As we improve our understanding of the molecular bases of disease, the possibilities of intervening with molecular tools are multiplying. We need a XXI-century chemistry that is subtle and complex, and that will be able to design any type of molecule. One that is not limited to what we currently have to see if it works, but that will be able to tailor specific molecules from natural products. In other words, a chemistry that is capable of pushing the limits of complexity of synthesis.»
President of the Foundation of the National Institutes of Health and President of the IRB Barcelona Business Advisory Board
«Sometimes the best way to make research useful for society is to publish and bring new knowledge into public arena. Sometimes inventions also need to a patent to guarantee that discoveries can be commercialised and provide incentives for pharmaceutical companies to develop drugs. It depends.»
«Our Friedrich's Ataxia project is maginificent because it has come about from the patients. It reminds us that answers are provided by basic research, the cornerstone of all future applications.»
More on this news here.
IRB Barcelona Alumni
«I'm sure that everything I learned at IRB Barcelona, a scientist, as a PhD student representative, and as a communication officer will help me in the new steps of my career.»
Imperial Cancer Research Fund London and member of the IRB Barcelona External Advisory Board
«IRB Barcelona is gaining a fine international reputation. Since it was founded in 2005, it has attracted talented group leaders, postdocs and graduate students from around the world. Prestigious awards and grants are flowing in and its training programmes are in full bloom. Innovation activities are beginning to pay off and its outreach programmes are extending the institute’s positive influence to the community.»
2001 Nobel Prize Laureate in Physiology and Medicine
Claudio Di Sanza
«At IRB Barcelona I found a solid scientifc project, and the opportunity to 'contaminate' myself working with biophysicists. The solvency of the Institute, the competitiveness of the science together with the unparalleled quality of lifeof the city convinced me that this was the best choice for my career.»
«Our goal is to give IRB Barcelona PhD students the quality training and support they need to become independent thinkers, setting a solid basis for their scientific careers.»
Chair of Graduate Training
The official newsletter of the IRB Barcelona community provides information about science-related initiatives and opinions of the people behind...
A 10-page colouring book with fun and fanciful pictures of the world of biomedical science. For our budding scientists of the future!
The IRB Barcelona brochures offer a general overview of the Institute’s research activities.
IRB Barcelona needs the help of Laura and Joan for a very important project. They will do research on cancer, using fruit flies, in order to...
The Annual Report provides an overview of the activities and developments that have taken place within the IRB Barcelona research community during...
This booklet comprises a series of articles that address the current situation of women in science. The articles have been written by four women...
Science Stories from IRB Barcelona is a book aimed at a non-specialist audience that features a selection of research projects currently being...